Ferritin Specific Neutra™ Antibody Products

Are you struggling with unreliable biomarkers for iron-related disorders or inefficient therapeutic targeting of ferrotoxic conditions? Creative Biolabs' ferritin-specific Neutra™ Antibody Products overcome these hurdles with high-affinity, isoform-selective antibodies engineered through advanced epitope mapping and conformational stability assays, empowering precise detection, quantification, and functional modulation of ferritin in diverse research and clinical settings.

Introduction to Ferritin

Ferritin, a widespread iron-storage protein, serves as the primary reservoir for intracellular iron homeostasis. Composed of 24 subunits forming a hollow nanocage, it sequesters excess ferrous iron (Fe²⁺) in a non-toxic, bioavailable form. Two subunit types—heavy chain (FTH1) and light chain (FTL)—orchestrate iron oxidation (FTH1) and nucleation (FTL). Expressed across tissues, ferritin levels in serum correlate with systemic iron status, inflammation, and cellular stress, making it a critical biomarker and therapeutic target.

• Structural Insights

The ferritin nanocage (450 kDa) self-assembles into a symmetric architecture with 8 nm pores, permitting iron entry and release. FTH1 contains ferroxidase centers that catalyze Fe²⁺ oxidation to Fe³⁺, while FTL promotes iron-mineral core formation. Structural plasticity allows dynamic iron loading/unloading, modulated by pH and redox signals. Cryo-EM studies reveal subunit-specific conformational changes during iron storage, offering targets for functional antibody intervention.

• Related Signaling Pathways

Ferritin intersects with iron-regulated proteins (IRPs) and the IRE/IRP system, controlling translational regulation of iron metabolism genes. It interacts with nuclear receptor coactivator 4 (NCOA4) during ferritinophagy—a selective autophagic process for iron release. Dysregulation activates oxidative stress pathways (e.g., Nrf2/KEAP1, NF-κB), linking ferritin to inflammation, apoptosis, and ferroptosis.

Fig.1 The regulatory mechanisms of ferritin expression.¹

• Disease Associations

Elevated serum ferritin signifies iron overload disorders (hereditary hemochromatosis, thalassemia), chronic inflammation (rheumatoid arthritis), or neurodegenerative diseases (Alzheimer's, Parkinson's), where iron accumulation exacerbates neuronal damage. Conversely, hypoferritinemia indicates iron deficiency or rare genetic mutations (e.g., neuroferritinopathy). Targeting ferritin offers diagnostic and therapeutic avenues to mitigate ferrotoxicity.

Applications of Anti-Ferritin Neutralizing Antibodies

• Diagnostic Tool Development

Anti-ferritin antibodies underpin assays for serum ferritin quantification, a gold-standard biomarker for iron dysregulation. Their high specificity minimizes cross-reactivity with acute-phase proteins, ensuring accurate differentiation between iron overload and inflammatory hyperferritinemia.

• Therapeutic Potential in Iron Overload Disorders

Neutralizing antibodies targeting FTH1 inhibit ferroxidase activity, reducing iron storage capacity and mitigating tissue damage in hemochromatosis models. In preclinical studies, antibody-mediated ferritin inhibition synergizes with iron chelators to improve iron mobilization.

• Neurodegenerative Disease Research

Antibodies capable of destabilizing ferritin's iron core facilitate studies on iron-mediated neurotoxicity. By preventing iron retention in microglia, these reagents reduce ROS production and neuronal death in Parkinson's disease cell models.

• Cancer Ferroptosis Modulation

In tumors reliant on ferroptosis resistance, anti-ferritin antibodies disrupt iron sequestration, sensitizing cancer cells to lipid peroxidation. This strategy enhances the efficacy of ferroptosis-inducing therapies in aggressive carcinomas.

Our Anti-Ferritin Antibody Products

Creative Biolabs' ferritin-specific Neutra™ antibody products redefine precision in iron metabolism research and therapeutic development. With rigorously validated specificity and neutralizing efficacy, our portfolio accelerates breakthroughs in diagnostics, neurodegenerative disease, and oncology. Our ferritin-specific antibodies exhibit unparalleled specificity for conformational epitopes on FTH1/FTL, enabling:

- Quantitative Accuracy: Reliable ELISA/Western blot quantification of serum/tissue ferritin isoforms.

- Functional Neutralization: Blocking ferritin-iron interactions to modulate intracellular iron flux in vitro and in vivo.

- Subcellular Resolution: Immunofluorescence and IHC applications to map ferritin distribution in pathological tissues.

Validated across species and sample types, these antibodies are indispensable for unraveling ferritin's dual role as a guardian and perpetrator of disease. Contact our team today to explore customized solutions for your ferritin-focused projects.

REFERENCE

1. Gehrer, Clemens M., et al. "Advances in ferritin physiology and possible implications in bacterial infection." International journal of molecular sciences 24.5 (2023): 4659. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms24054659